“Leading biotech company RiboPro has launched a Series A funding round that will help them open two international offices and cultivate client relationships. In the future, RiboPro will upgrade tech and secure more pivotal partnerships.” Click here to read more about Biotech Scale-up RiboPro Announces Funding Round To Support Preclinical Development and International Expansion.
Biotech Scale-up RiboPro Announces Funding Round To Support Preclinical Development and International Expansion
A recent news article about RIBOPRO's launch for a Series A funding round is published on the website of Bloomberg.
RiboWorld
Latest articles
Partnership
RIBOPRO and IPA Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in Immunotherapy
Fund raising
RIBOPRO Secures Series A Funding to Accelerate mRNA-Based technologies
Fund raising
RIBOPRO Secures €1.9M Convertible Loan Agreement, Paving the Way for Series A Financing